Emerging concepts in heart failure management and treatment: focus on vericiguat

The nitric oxide (NO)–soluble guanylate cyclase (sGC)–cyclic guanosine monophosphate (cGMP) pathway is dysregulated in patients with heart failure (HF) resulting in myocardial and vascular dysfunction that contributes to its progression. Vericiguat is a novel direct sGC stimulator that targets in at...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplinsky, Edgardo, Perrone, Sergio, Barbagelata, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828868/
https://www.ncbi.nlm.nih.gov/pubmed/36660012
http://dx.doi.org/10.7573/dic.2022-5-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828868/
https://www.ncbi.nlm.nih.gov/pubmed/36660012
http://dx.doi.org/10.7573/dic.2022-5-5

Ejemplares similares